High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study
2019-20 coronavirus outbreak
Betacoronavirus
DOI:
10.3346/jkms.2024.39.e255
Publication Date:
2024-08-05T07:34:24Z
AUTHORS (4)
ABSTRACT
Systemic corticosteroids have become the standard of care for severe to critically ill patients with coronavirus disease 2019 (COVID-19). However, real-world efficacy and safety outcomes associated a higher dose remain uncertain.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....